# Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)

> **NCT00423488** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 93 (actual)

## Conditions studied

- Hypercholesterolemia
- Diabetes Mellitus, Type 2
- Coronary Disease

## Interventions

- **DRUG:** Ezetimibe 10 mg
- **DRUG:** Simvastatin 20 mg
- **DRUG:** Ezetimibe Placebo
- **DRUG:** Simvastatin 20 mg
- **DRUG:** Simvastatin Placebo

## Key facts

- **NCT ID:** NCT00423488
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07-12
- **Primary completion:** 2007-02-16
- **Final completion:** 2007-02-16
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2022-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00423488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00423488, "Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00423488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*